CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by progressive increase in pulmonary vascular resistance (PVR), higher pulmonary arteries mean pressure (mPAP), decrease in cardiac minute output (CMO) and other hemodynamic, functional and biochemical disorders. Exist...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
InterMedservice
2018-06-01
|
| Serie: | Евразийский Кардиологический Журнал |
| Soggetti: | |
| Accesso online: | https://www.heartj.asia/jour/article/view/287 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|